| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |